Connection

SETH LERNER to Animals

This is a "connection" page, showing publications SETH LERNER has written about Animals.
Connection Strength

0.213
  1. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. Urol Oncol. 2009 Jul-Aug; 27(4):391-9.
    View in: PubMed
    Score: 0.017
  2. Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol. 2007 Dec; 52(6):1708-9.
    View in: PubMed
    Score: 0.017
  3. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. Eur Urol. 2005 Jul; 48(1):69-76.
    View in: PubMed
    Score: 0.014
  4. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight. 2024 Sep 10; 9(17).
    View in: PubMed
    Score: 0.013
  5. Paternal influences on turkey embryonic growth in the absence of changes in egg weight and eggshell conductance. Poult Sci. 2000 Dec; 79(12):1810-6.
    View in: PubMed
    Score: 0.010
  6. Correlation of body weight with hatchling blood glucose concentration and its relationship to embryonic survival. Poult Sci. 2000 Dec; 79(12):1817-22.
    View in: PubMed
    Score: 0.010
  7. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther. 2000 Sep; 2(3):211-7.
    View in: PubMed
    Score: 0.010
  8. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter. Anticancer Res. 2000 Sep-Oct; 20(5A):2811-6.
    View in: PubMed
    Score: 0.010
  9. Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000 May-Jun; 20(3A):1359-65.
    View in: PubMed
    Score: 0.010
  10. Current status of gene therapy for prostate and bladder cancer. Int J Urol. 1997 Sep; 4(5):435-40.
    View in: PubMed
    Score: 0.008
  11. Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80.
    View in: PubMed
    Score: 0.008
  12. Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise. Clin Cancer Res. 2015 Oct 15; 21(20):4514-24.
    View in: PubMed
    Score: 0.007
  13. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 2015 Jan 08; 517(7533):209-13.
    View in: PubMed
    Score: 0.007
  14. Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage. Anticancer Drugs. 2014 Sep; 25(8):878-86.
    View in: PubMed
    Score: 0.007
  15. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3377-82.
    View in: PubMed
    Score: 0.007
  16. The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9.
    View in: PubMed
    Score: 0.007
  17. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma. Urol Oncol. 2013 Feb; 31(2):234-40.
    View in: PubMed
    Score: 0.005
  18. Ontogeny of corticotropin releasing hormone gene expression in rat hypothalamus--comparison with somatostatin. Int J Dev Neurosci. 1991; 9(5):473-8.
    View in: PubMed
    Score: 0.005
  19. Age-related immunohistochemical studies of A and D cells in pancreatic islets of C57BL/6J mice. Anat Rec. 1990 Sep; 228(1):53-7.
    View in: PubMed
    Score: 0.005
  20. Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling. Mol Cancer Ther. 2010 May; 9(5):1128-35.
    View in: PubMed
    Score: 0.005
  21. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Mol Cancer Ther. 2009 Jul; 8(7):1772-8.
    View in: PubMed
    Score: 0.005
  22. Genotypic influences on reproductive aging of inbred female mice: effects of H-2 and non-H-2 alleles. Biol Reprod. 1988 Jun; 38(5):1035-43.
    View in: PubMed
    Score: 0.004
  23. Blood vessel matrix: a new alternative for abdominal wall reconstruction. Hernia. 2008 Aug; 12(4):351-8.
    View in: PubMed
    Score: 0.004
  24. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology. 2007 Jun; 69(6):1221-6.
    View in: PubMed
    Score: 0.004
  25. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res. 2004 Oct 15; 64(20):7355-60.
    View in: PubMed
    Score: 0.003
  26. Field testing the influence of sperm competition based on sperm mobility in breeder turkey toms. Br Poult Sci. 2003 Jul; 44(3):498-504.
    View in: PubMed
    Score: 0.003
  27. L-asparaginase and PEG asparaginase--past, present, and future. Leuk Lymphoma. 1993; 10 Suppl:153-7.
    View in: PubMed
    Score: 0.001
  28. Unilateral ovariectomy increases loss of primordial follicles and is associated with increased metestrous concentration of follicle-stimulating hormone in old rats. Biol Reprod. 1992 Aug; 47(2):162-8.
    View in: PubMed
    Score: 0.001
  29. Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Brain Res Mol Brain Res. 1989 May; 5(3):203-9.
    View in: PubMed
    Score: 0.001
  30. Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration. Pharmacol Res. 1989 May-Jun; 21(3):299-311.
    View in: PubMed
    Score: 0.001
  31. Rapid corticosterone-induced changes in gene expression in rat hippocampus display type II glucocorticoid receptor specificity. Mol Endocrinol. 1988 Mar; 2(3):284-90.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.